Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.
A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond ...
As global temperatures rise, Cold Spring Harbor Laboratory (CSHL) scientists work to grow stronger, more resilient crops. Yet ...
To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...
On a video call in early September, Sarah Tabrizi first saw the data that she and other researchers studying Huntington’s ...
CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...
Frankenstein fungi that tastes similar to meat and is easy to digest has been created. The genetically engineered food is ...
Discover how scientists engineered goldenberry plants to grow 35% shorter than usual, making them suitable for large-scale ...
This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results